LRRK2 and neurodegenerative disease: Given that both loss of LRRK2 function and the kinase-activating LRRK2 G2019S mutation disrupt the endolysosomal system, uptake of additional cargoes relevant to neurodegenerative disease were analysed in the different LRRK2 genotypes (Fig. 6D–F).